Concepedia
Statistics
Publications
56
Citations
6K
Authors
6
Location
Suzhou, China
PersonGen (China) is a company institution in Suzhou, China known for medicine, immunology, and immunotherapy.
Top concepts
MedicineImmunologyImmunotherapyT Cell ImmunityTumor ImmunityRadiation OncologyAutoimmunityCell BiologyCell TherapyCell Transplantation
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.
Xiaowen Tang, Lin Yang, Zheng Li et al. · PubMed · 2018 · 412 citations · Full text
Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
Fengtao You, Licui Jiang, Bozhen Zhang et al. · Science China Life Sciences · 2016 · 148 citations · Full text
A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia.
Fengtao You, Yinyan Wang, Licui Jiang et al. · PubMed · 2019 · 130 citations · Full text
Immunology, Immunoediting, Immunodominance +19
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
Mingzhi Zhang, Dan Chen, Xiaorui Fu et al. · Clinical Cancer Research · 2022 · 105 citations · Full text
<p>Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma</p>
Sujun Li, Lei Xue, Min Wang et al. · OncoTargets and Therapy · 2019 · 54 citations · Full text
1–5 of 56
PersonGen (China), China
67 publications · 1K citations
13
h-index
59 publications · 1.1K citations
12
16 publications · 42 citations
4
20 publications · 47 citations
6 publications · 197 citations
1–5 of 6